Inside the Lab Industry: Q2 Earnings Decline Despite Rebound in Core Business
Though COVID-19 testing declines continue to negatively affect lab industry profits, the latest figures suggest the worst may be over.
Earnings-lir
Subscribe today for access to
Articles and Reports
Inside the Lab Industry: COVID-19 Declines Kill Top Lab Company Earnings but Genetic Firms Rebound
Yet, despite these declines, Q1 was neither as bad as expected nor totally devoid of positive signs for the future.
COVID-19 Losses Take a Toll on Q4 Earnings—but It Could Have Been Worse
Though Q4 earnings in the lab industry took a beating as predicted, the earnings picture wasn’t nearly as bleak as many had feared.
Q3 Lab Company Earnings Take a Hit
A decline in COVID-19 testing demand, along with a challenging economy, made for a difficult quarter for diagnostics companies.
FY 2022 Q2 Earnings Trend Down, but Much Less than Predicted
While not nearly as robust as a year ago, diagnostic companies’ revenues held up surprisingly well in Q2 2022.
COVID-19 Test Profits Make Labs Potential Target for Public Backlash
Independent labs accrued a profit of at least $10 on each PCR COVID-19 test performed in the period from May to December 2020, study says.
FY 2022 Q1 Could Be the Last Hurrah for the COVID Earnings Surge
Most diagnostics companies experienced modest, flat, or negative top-line revenue growth rates in the first quarter of 2022.
Q3 Diagnostics Revenues Remain Strong Despite Fall in COVID-19 Testing
...
Already a member? Log in here
Resurgence of COVID-19 Cases Threatens to Derail Recovery of Core Business
...
Already a member? Log in here
COVID-19 Continues Driving Growth but in a New Way as Core Revenues Rebound
...
Already a member? Log in here
COVID-19 Surge Lifts Overall Molecular Point of Care Testing Market to $900 Million
...
Already a member? Log in here
COVID-19 Drives Unprecedented but Ultimately Unsustainable Growth
...
Already a member? Log in here
